These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 26930662)

  • 21. Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals.
    Peirano G; Costello M; Pitout JD
    Int J Antimicrob Agents; 2010 Jul; 36(1):19-23. PubMed ID: 20359869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Temporal changes in the prevalence of community-acquired antimicrobial-resistant urinary tract infection affected by Escherichia coli clonal group composition.
    Smith SP; Manges AR; Riley LW
    Clin Infect Dis; 2008 Mar; 46(5):689-95. PubMed ID: 18230040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CTX-M-15-producing Escherichia coli clinical isolates in Cairo (Egypt), including isolates of clonal complex ST10 and clones ST131, ST73, and ST405 in both community and hospital settings.
    Fam N; Leflon-Guibout V; Fouad S; Aboul-Fadl L; Marcon E; Desouky D; El-Defrawy I; Abou-Aitta A; Klena J; Nicolas-Chanoine MH
    Microb Drug Resist; 2011 Mar; 17(1):67-73. PubMed ID: 21128836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Escherichia coli bacteraemia: 2 years of prospective regional surveillance (2010-12).
    Horner C; Fawley W; Morris K; Parnell P; Denton M; Wilcox M
    J Antimicrob Chemother; 2014 Jan; 69(1):91-100. PubMed ID: 24003184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clonal composition and community clustering of drug-susceptible and -resistant Escherichia coli isolates from bloodstream infections.
    Adams-Sapper S; Diep BA; Perdreau-Remington F; Riley LW
    Antimicrob Agents Chemother; 2013 Jan; 57(1):490-7. PubMed ID: 23147723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Escherichia coli sequence type 131 is a dominant, antimicrobial-resistant clonal group associated with healthcare and elderly hosts.
    Banerjee R; Johnston B; Lohse C; Porter SB; Clabots C; Johnson JR
    Infect Control Hosp Epidemiol; 2013 Apr; 34(4):361-9. PubMed ID: 23466908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Absence of CTX-M enzymes but high prevalence of clones, including clone ST131, among fecal Escherichia coli isolates from healthy subjects living in the area of Paris, France.
    Leflon-Guibout V; Blanco J; Amaqdouf K; Mora A; Guize L; Nicolas-Chanoine MH
    J Clin Microbiol; 2008 Dec; 46(12):3900-5. PubMed ID: 18842941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Role of AcrAB-TolC Efflux Pumps on Quinolone Resistance of E. coli ST131.
    Atac N; Kurt-Azap O; Dolapci I; Yesilkaya A; Ergonul O; Gonen M; Can F
    Curr Microbiol; 2018 Dec; 75(12):1661-1666. PubMed ID: 30283991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MECHANISMS OF RESISTANCE TO CIPROFLOXACIN AND GENETIC DIVERSITY OF ESCHERICHIA COLI STRAINS ORIGINATING FROM URINE CULTURES PERFORMED FOR ROMANIAN ADULTS.
    Cristea VC; Oprea M; Neacşu G; Gîlcă R; Popa MI; Usein CR
    Roum Arch Microbiol Immunol; 2015; 74(3-4):73-8. PubMed ID: 27328520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular epidemiology of extraintestinal pathogenic Escherichia coli isolates from a regional cohort of elderly patients highlights the prevalence of ST131 strains with increased antimicrobial resistance in both community and hospital care settings.
    Croxall G; Hale J; Weston V; Manning G; Cheetham P; Achtman M; McNally A
    J Antimicrob Chemother; 2011 Nov; 66(11):2501-8. PubMed ID: 21862477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CTX-M-15-producing urinary Escherichia coli O25b-ST131-phylogroup B2 has acquired resistance to fosfomycin.
    Oteo J; Orden B; Bautista V; Cuevas O; Arroyo M; Martínez-Ruiz R; Pérez-Vázquez M; Alcaraz M; García-Cobos S; Campos J
    J Antimicrob Chemother; 2009 Oct; 64(4):712-7. PubMed ID: 19671590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular epidemiology and genetic diversity of fluoroquinolone-resistant Escherichia coli isolates from patients with community-onset infections in 30 Chinese county hospitals.
    Zhao L; Zhang J; Zheng B; Wei Z; Shen P; Li S; Li L; Xiao Y
    J Clin Microbiol; 2015 Mar; 53(3):766-70. PubMed ID: 25520451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and multidrug resistance of Escherichia coli from community-acquired infections in Lagos, Nigeria.
    Adenipekun EO; Jackson CR; Ramadan H; Iwalokun BA; Oyedeji KS; Frye JG; Barrett JB; Hiott LM; Woodley TA; Oluwadun A
    J Infect Dev Ctries; 2016 Sep; 10(9):920-931. PubMed ID: 27694724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emergence and spread of O16-ST131 and O25b-ST131 clones among faecal CTX-M-producing Escherichia coli in healthy individuals in Hunan Province, China.
    Zhong YM; Liu WE; Liang XH; Li YM; Jian ZJ; Hawkey PM
    J Antimicrob Chemother; 2015 Aug; 70(8):2223-7. PubMed ID: 25957581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bacteremia due to extended-spectrum beta -lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge.
    Rodríguez-Baño J; Navarro MD; Romero L; Muniain MA; de Cueto M; Ríos MJ; Hernández JR; Pascual A
    Clin Infect Dis; 2006 Dec; 43(11):1407-14. PubMed ID: 17083012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Community emergence of CTX-M type extended-spectrum beta-lactamases among urinary Escherichia coli from women.
    Ho PL; Poon WW; Loke SL; Leung MS; Chow KH; Wong RC; Yip KS; Lai EL; Tsang KW;
    J Antimicrob Chemother; 2007 Jul; 60(1):140-4. PubMed ID: 17496058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Occurrence of multidrug resistance to oral antibiotics among Escherichia coli urine isolates from outpatient departments in Germany: extended-spectrum β-lactamases and the role of fosfomycin.
    Kresken M; Pfeifer Y; Hafner D; Wresch R; Körber-Irrgang B;
    Int J Antimicrob Agents; 2014 Oct; 44(4):295-300. PubMed ID: 25223936
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibiotic Resistance, Virulence, and Genetic Background of Community-Acquired Uropathogenic Escherichia coli from Algeria.
    Yahiaoui M; Robin F; Bakour R; Hamidi M; Bonnet R; Messai Y
    Microb Drug Resist; 2015 Oct; 21(5):516-26. PubMed ID: 26430940
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms of resistance and mobility among multidrug-resistant CTX-M-producing Escherichia coli from Canadian intensive care units: the 1st report of QepA in North America.
    Baudry PJ; Nichol K; DeCorby M; Lagacé-Wiens P; Olivier E; Boyd D; Mulvey MR; Hoban DJ; Zhanel GG
    Diagn Microbiol Infect Dis; 2009 Mar; 63(3):319-26. PubMed ID: 19216943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CTX-M-1-related extended-spectrum beta-lactamases producing Escherichia coli: so far a sporadic event in Western Austria.
    Prelog M; Fille M; Prodinger W; Grif K; Brunner A; Würzner R; Zimmerhackl LB
    Infection; 2008 Aug; 36(4):362-7. PubMed ID: 18574554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.